MOLLY SCHOOLEY: Open Payments
NPI 1225332463 · DAKOTA DUNES, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,552 in 129 payments from 30 companies in 2025. Trend: 2023 $19,095 · 2024 $15,671 · 2025 $29,552
Speaker / faculty: $20,665Travel & lodging: $3,546Food & beverage: $2,982Consulting: $2,310Education: $50
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 37 | $22,594 |
| Bayer Healthcare Pharmaceuticals Inc. | 24 | $5,269 |
| Novo Nordisk AS | 1 | $330 |
| PFIZER INC. | 11 | $165 |
| Ascendis Pharma Endocrinology Inc | 5 | $163 |
| ABBVIE INC. | 10 | $153 |
| Insulet Corporation | 1 | $150 |
| Xeris Pharmaceuticals, Inc. | 5 | $81 |
| Mannkind Corporation | 2 | $63 |
| Astellas Pharma US Inc | 4 | $62 |
Products named: Ozempic, Kerendia, Yorvipath, OMNIPOD, Wegovy, ELIQUIS, JARDIANCE, VRAYLAR.
Industry payments across SD — which companies pay providers there.
